Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
Ágatha Oliveira‐Giacomelli, Yahaira Naaldijk, Laura Sardà‐Arroyo, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

From purines to purinergic signalling: molecular functions and human diseases
Zhao Huang, Na Xie, Péter Illés, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 302
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Deidiane Elisa Ribeiro, Ágatha Oliveira‐Giacomelli, Talita Glaser, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 4, pp. 1044-1059
Open Access | Times Cited: 126
The P2X7 Receptor: Central Hub of Brain Diseases
Roberta Andrejew, Ágatha Oliveira‐Giacomelli, Deidiane Elisa Ribeiro, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 115
Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors
Mercedes Garcia‐Gil, Marcella Camici, S. Allegrini, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3598-3598
Open Access | Times Cited: 65
Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases
Shehata Anwar, Vincent Pons, Serge Rivest
Cells (2020) Vol. 9, Iss. 7, pp. 1595-1595
Open Access | Times Cited: 48
P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease
Ágatha Oliveira‐Giacomelli, Carolina M. Albino, Héllio D. N. de Souza, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 47
P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo, Hamideh Zarrinmayeh
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37
Mechanisms of astrocytic and microglial purinergic signaling in homeostatic regulation and implications for neurological disease
Moawiah M. Naffaa
Exploration of neuroscience (2025)
Open Access
Microglia in Neurodegenerative Events—An Initiator or a Significant Other?
G. Jean Harry
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5818-5818
Open Access | Times Cited: 29
Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies
Giulia Magni, Benedetta Riboldi, Stefania Ceruti
Cells (2024) Vol. 13, Iss. 7, pp. 606-606
Open Access | Times Cited: 4
P2Y6 Receptor: A Promising Therapeutic Target for Atherosclerosis
Lixia Li, L. Lai, Dan Qiu, et al.
European Journal of Pharmacology (2025), pp. 177513-177513
Closed Access
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
Adrián Tóth, Zsófia Antal, Dániel Bereczki, et al.
Neurochemical Research (2019) Vol. 44, Iss. 10, pp. 2413-2422
Open Access | Times Cited: 35
Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington’s and Parkinson’s Disease
Talita Glaser, Roberta Andrejew, Ágatha Oliveira‐Giacomelli, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1299-1314
Open Access | Times Cited: 28
Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation
Elias Rawish, Harald F. Langer
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6585-6585
Open Access | Times Cited: 18
P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases
A. S. Zelentsova, Alexey V. Deykin, Vladislav O. Soldatov, et al.
eNeuro (2022) Vol. 9, Iss. 6, pp. ENEURO.0092-22.2022
Open Access | Times Cited: 16
Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
Tom J. Phillips, Emily Maguire
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 22
Purinergic signaling in nervous system health and disease: Focus on pannexin 1
Juan C. Sanchez‐Arias, Emma van der Slagt, Haley A. Vecchiarelli, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107840-107840
Closed Access | Times Cited: 21
P2X7 receptor of microglia in olfactory bulb mediates the pathogenesis of olfactory dysfunction in a mouse model of allergic rhinitis
Chao Ren, Yakui Mou, Xiao‐Yu Song, et al.
The FASEB Journal (2023) Vol. 37, Iss. 6
Closed Access | Times Cited: 7
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics
Yanshuo Guo, Tianqi Mao, Yafei Fang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders
Federico Mucci, Donatella Marazziti, Alessandra Della Vecchia, et al.
Life (2020) Vol. 10, Iss. 6, pp. 82-82
Open Access | Times Cited: 18
Depression Induced by Chronic Unpredictable Mild Stress Increases Susceptibility to Parkinson’s Disease in Mice via Neuroinflammation Mediated by P2X7 Receptor
Chao Ren, Ling-Xi Li, An-Qi Dong, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1262-1272
Closed Access | Times Cited: 16
Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease
Pradeep Singh, Garima Mishra, Mulugeta Molla, et al.
Journal of Functional Foods (2022) Vol. 92, pp. 105047-105047
Open Access | Times Cited: 10
Neuroprotective effect of aloe emodin against Huntington's disease-like symptoms in R6/1 transgenic mice
Nan Yan, Shuai Wang, Haotian Gao, et al.
Food & Function (2023) Vol. 14, Iss. 11, pp. 5205-5216
Closed Access | Times Cited: 5
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
Júlia Leão Batista Simões, Julia Beatrice de Araújo, Margarete Dulce Bagatini
Molecular Neurobiology (2021) Vol. 58, Iss. 10, pp. 5090-5111
Open Access | Times Cited: 12
Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis
Cinzia Volonté, Susanna Amadio
Neuropharmacology (2022) Vol. 221, pp. 109278-109278
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top